Ben Khaled, Najib; Ehmer, Ursula; Kubisch, Ilja; Gonzalez-Carmona, Maria A.; Philipp, Alexander; Seidensticker, Max; Altenhofer, Julia; Basch, Marion; Hüwer, Tim; Oehrle, Bettina; Geier, Andreas; Soldà, Caterina; Auriemma, Alessandra; Bauer, Ulrike; Zhou, Taotao; Perkhofer, Lukas; Chater, Jack; Weinmann, Arndt; Felden, Johann von; De Rosa, Antonio; Vivaldi, Caterina; Piseddu, Ignazio; Schwald, Isabel; Enssle, Stefan; Karin, Monika; Schneider, Julia S.; Gröper, Moritz N.; Ondrejkova, Katarina; Weiss, Lena; Beyer, Georg; Schulze, Kornelius; Antonuzzo, Lorenzo; Masi, Gianluca; Daniele, Bruno; Ricke, Jens; Mayerle, Julia; Foerster, Friedrich; Reiter, Florian P.; Ettrich, Thomas J.; De Toni, Enrico N. (2026): Sequential or upfront triple combination with durvalumab, tremelimumab, and bevacizumab for patients with unresectable hepatocellular carcinoma: the MONTBLANC trial protocol (AIO-HEP-0325/ass). Therapeutic Advances in Medical Oncology, 18. pp. 1-14. ISSN 1758-8359

Piseddu, Ignazio; Jochheim, Leonie S.; Boettcher, Katrin; Scheiner, Bernhard; Sinner, Friedrich; Gairing, Simon Johannes; Thaler, Matthias; Enssle, Stefan; Karin, Monika; Zarka, Valentina; Philipp, Alexander; Thalmeier, Andreas; Gaertig, Jan; Balcar, Lorenz; Schütte, Julia Martina; Schneider, Julia S.; Ondrejkova, Katarina; Rau, Monika; Weich, Alexander; Anz, David; Berger, Karin; Schulz, Christian; Lange, Christian M.; Öcal, Osman; Alunni-Fabbroni, Marianna; Ricke, Jens; Ehmer, Ursula; Venerito, Marino; Foerster, Friedrich; Pinter, Matthias; Geier, Andreas; Mayerle, Julia; De Toni, Enrico N.; Reiter, Florian P.; Ben Khaled, Najib (2025): Early mortality in atezolizumab/bevacizumab for HCC is associated with impaired liver function and alterations of systemic immunity. JHEP Reports, 7 (11): 101513. ISSN 25895559

Becht, Selina; Ben Khaled, Najib; Schrodi, Simone; von Bergwelt-Baildon, Michael; Buggisch, Peter; Crispin, Alexander; Hofmann, Wolf-Peter; Marschall, Ursula; Mayerle, Julia; Mörtl, Bernhard; Orabi, Sami; Philipp, Alexander; Trojan, Jörg; Weiglein, Tobias; De Toni, Enrico N.; Berger-Thürmel, Karin (2025): What can claims data tell us about risk factors and survival of patients with hepatocellular carcinoma? Insights from a German population-based study. Frontiers in Oncology, 15: 1650982. ISSN 2234-943X

Koch, Dominik T.; Yu, Haochen; Beirith, Iris; Schirren, Malte; Drefs, Moritz; Liu, Yunfei; Knoblauch, Mathilda; Koliogiannis, Dionysios; Sheng, Weiwei; De Toni, Enrico N.; Bazhin, Alexandr V.; Renz, Bernhard W.; Guba, Markus O.; Werner, Jens; Ilmer, Matthias (2023): Tigecycline causes loss of cell viability mediated by mitochondrial OXPHOS and RAC1 in hepatocellular carcinoma cells. Journal of Translational Medicine, 21 (1). ISSN 1479-5876

Schütte, Kerstin; Kupčinskas, Juozas; Morkunas, Egidijus; Öcal, Osman; Schinner, Regina; Seidensticker, Max; De Toni, Enrico N.; Ben Khaled, Najib; Pech, Maciej; Palmer, Daniel; Berg, Thomas; Sengel, Christian; Basu, Bristi; Valle, Juan W.; Benckert, Julia; Gasbarrini, Antonio; Sangro, Bruno; Malfertheiner, Peter; Ricke, Jens (2022): Dynamics in Circulating y -55Proinflammatory Biomarkers for Prognostic Assessment of Patients With Advanced HCC – A Substudy From the SORAMIC Trial. Frontiers in Gastroenterology, 1. ISSN 2813-1169